07 Oct 2022
Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials
Summary
Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.
Learning Objectives
- To learn how non-inferiority trials are different from superiority trials
- To understand the concept of non-inferiority margin, and its interpretation
- To apply the results of the MASTER-DAPT and FAME-3 trials in everyday clinical practice
